Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.

[1]  R. Globus,et al.  Effects of simulated weightlessness on bone mineral metabolism. , 1984, Endocrinology.

[2]  D. Bikle,et al.  Bone response to normal weight bearing after a period of skeletal unloading. , 1989, The American journal of physiology.

[3]  P. Simonian,et al.  Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. , 1993, The Journal of biological chemistry.

[4]  P. Nijweide,et al.  Function of osteocytes in bone , 1994, Journal of cellular biochemistry.

[5]  A. Parfitt.  Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone , 1994, Journal of cellular biochemistry.

[6]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[7]  Roberto Pacifici,et al.  Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. Reeve,et al.  The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. , 1997, The Journal of clinical endocrinology and metabolism.

[9]  L. Bonewald,et al.  Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  D. Bikle,et al.  The response of bone to unloading , 1999, Journal of Bone and Mineral Metabolism.

[11]  J. Klein-Nulend,et al.  MECHANOTRANSDUCTION IN BONE : ROLE OF THE LACUNOCANALICULAR NETWORK , 1999 .

[12]  Matthew J. Silva,et al.  Growing C57Bl/6 Mice Increase Whole Bone Mechanical Properties by Increasing Geometric and Material Properties , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  N. Amizuka,et al.  Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage. , 1999, The Journal of clinical investigation.

[14]  R. Weinstein,et al.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. , 2000, The Journal of clinical endocrinology and metabolism.

[15]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[16]  Hiroshi Takayanagi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.

[17]  H. Yonekawa,et al.  Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice , 2001, Nature Biotechnology.

[18]  T. Komori,et al.  Dentin Matrix Protein 1 Is Predominantly Expressed in Chicken and Rat Osteocytes But Not in Osteoblasts , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  T. Takano-Yamamoto,et al.  A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. , 2001, Bone.

[20]  A. Parfitt.  Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. , 2002, Bone.

[21]  Ego Seeman,et al.  Pathogenesis of bone fragility in women and men , 2002, The Lancet.

[22]  L. Lanyon,et al.  Mechanical Strain and Bone Cell Function: A Review , 2002, Osteoporosis International.

[23]  D. Rao,et al.  Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. , 2002, Bone.

[24]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[25]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[26]  Matthew J. Silva,et al.  SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts , 2002, Nature Network Boston.

[27]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[28]  John A Latham,et al.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.

[29]  Gideon A. Rodan,et al.  Control of osteoblast function and regulation of bone mass , 2003, Nature.

[30]  S. Teitelbaum,et al.  Genetic regulation of osteoclast development and function , 2003, Nature Reviews Genetics.

[31]  Y. Takeuchi,et al.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.

[32]  M. Karperien,et al.  Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist , 2004, The Journal of experimental medicine.

[33]  Xi Jiang,et al.  Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. , 2004, Bone.

[34]  Hajime Orimo,et al.  Multi‐Detector Row CT Imaging of Vertebral Microstructure for Evaluation of Fracture Risk , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  L. Bonewald,et al.  Dentin Matrix Protein 1 Gene Cis-regulation , 2005, Journal of Biological Chemistry.

[36]  L. Bonewald,et al.  Dmp1-deficient Mice Display Severe Defects in Cartilage Formation Responsible for a Chondrodysplasia-like Phenotype* , 2005, Journal of Biological Chemistry.

[37]  Peng Liu,et al.  Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling* , 2005, Journal of Biological Chemistry.

[38]  L. Raisz.  Pathogenesis of osteoporosis: concepts, conflicts, and prospects. , 2005, The Journal of clinical investigation.

[39]  J. Reeve,et al.  The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB , 2022 .

[40]  T. Martin,et al.  Osteoclast-derived activity in the coupling of bone formation to resorption. , 2005, Trends in molecular medicine.

[41]  Hector F Rios,et al.  DMP1 Depletion Decreases Bone Mineralization In Vivo: An FTIR Imaging Analysis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  B. Hall,et al.  Buried alive: How osteoblasts become osteocytes , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[43]  C. Cooper,et al.  Osteoporosis: trends in epidemiology, pathogenesis and treatment , 2006 .

[44]  Xi Jiang,et al.  Pathogenic role of Fgf23 in Hyp mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[45]  L. Bonewald,et al.  Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism , 2006, Nature Genetics.

[46]  P. Delmas,et al.  Bone quality--the material and structural basis of bone strength and fragility. , 2006, The New England journal of medicine.